Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2010
12/07/2010CA2256543C Methods and compositions useful for inhibition of angiogenesis
12/02/2010WO2010137939A1 Method for producing a nutraceutical composition and the nutraceutical produced by the method
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137020A1 Methods of treating inflammation
12/02/2010WO2010136491A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010WO2010115278A8 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
12/02/2010WO2010103547A3 Substituted fused pyrimidine compounds
12/02/2010WO2010103017A3 Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
12/02/2010WO2010057028A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
12/02/2010WO2010049438A3 Improved methods of using phosphoantigens for the treatment of diseases
12/02/2010WO2000045847A8 Novel mucosal delivery system
12/02/2010US20100306863 Screening, therapy and diagnosis
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305197 Conditionally Active Ribozymes And Uses Thereof
12/02/2010US20100305196 COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305187 Methods and compounds for treating diseases caused by reactive oxygen species
12/02/2010US20100305186 Methods for mediating gene suppression
12/02/2010US20100305174 Novel Heterocyclic Derivatives
12/02/2010US20100305164 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/02/2010US20100305159 Crystalline form of piperidine compound
12/02/2010US20100305151 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders
12/02/2010US20100305123 Class of histone deacetylase inhibitors
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305113 Substituted Imidazopyridazines as Lipid Kinase Inhibitors
12/02/2010US20100305098 Methods of use
12/02/2010US20100305096 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305094 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/02/2010US20100305093 Inhibitors of mTOR and Methods of Making and Using
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305077 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
12/02/2010US20100305066 Fused Thiophene Derivatives as Kinase Inhibitors
12/02/2010US20100305049 Novel Wheat Allergens
12/02/2010US20100305038 Diagnostic of immune graft tolerance using tmtc3 gene expression levels
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305033 Hydroxyalkyl starch derivatives and process for their preparation
12/02/2010US20100305024 Methods of inhibiting calcineurin with apoe analogs
12/02/2010US20100305023 Method of Delaying The Onset of Clinically Definite Multiple Sclerosis
12/02/2010US20100303933 Immunopotentiating composition from labisia pumila extract
12/02/2010US20100303921 Pharmaceutical Compositions Comprising Cereal Beta (1-3) Beta (1-4) Glucan
12/02/2010US20100303899 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/02/2010US20100303867 a composition comprising a notch ligand and an allergenb or allergen bystander antigen
12/02/2010US20100303866 Immunogenic peptides and their use in immune disorders
12/02/2010US20100303862 Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
12/02/2010US20100303858 Chimeric HIV-1 Glycoproteins and Their Biological Applications
12/02/2010US20100303851 Immunostimulation by chemically modified rna
12/02/2010US20100303850 Nanocarriers possessing components with different rates of release
12/02/2010US20100303849 Lipidated Vaccine against Dengue Virus Infection
12/02/2010US20100303847 Compositions of toll-like receptor agonists and papillomavirus antigens and methods of use thereof
12/02/2010US20100303846 Immunostimulatory Nucleic Acid Packaged Particles for the Treatment of Hypersensitivity
12/02/2010US20100303845 Novel gene expressed in prostate cancer
12/02/2010US20100303844 Modification of intrinsically disordered sequences for the preparation of vaccines
12/02/2010US20100303843 RECOMBINANT ALLERGEN WITH REDUCED lgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
12/02/2010US20100303842 Peptide analogues
12/02/2010US20100303838 Vectors for multiple gene expression
12/02/2010US20100303835 Peptoid ligands for isolation and treatment of autoimmune t-cells
12/02/2010US20100303833 Method for Identifying a MHC Class H-Dependent Tumor Associated T Helper Cell Antigen
12/02/2010US20100303826 Use of ADCC-Optimized antibodies for treating weak patients
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303812 Neutralizing monoclonal antibody against human dll4
12/02/2010US20100303811 Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity.
12/02/2010US20100303808 Humanized anti-cd20 antibodies and methods of use
12/02/2010US20100303806 Avian derivedantibodies
12/02/2010US20100303781 Treatment
12/02/2010US20100303780 Compositions for treating an intestinal inflammatory condition
12/02/2010US20100303777 Delivery of binding molecules to induce immunomodulation
12/02/2010US20100303766 Cell population with enhanced transplantation activity
12/02/2010US20100303741 Wolfberries and inflammation
12/02/2010US20100303721 Use of Parasitic Biological Agents for Diseases Prevention and Control
12/02/2010US20100303717 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials Cross Reference to Related Applications
12/02/2010CA2772371A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010CA2763638A1 Iap inhibitors
12/02/2010CA2763614A1 Iap inhibitors
12/02/2010CA2762653A1 Immunomodulatory agent-polymeric compounds
12/02/2010CA2762650A1 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
12/02/2010CA2762647A1 Nanocarriers possessing components with different rates of release
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
12/01/2010EP2255826A2 Neisserial vaccine compositions comprising a combination of antigens
12/01/2010EP2255824A1 Immunosuppression using Chaperonin 10
12/01/2010EP2255823A1 Intestinal immune system stimulator
12/01/2010EP2255820A1 Use of parasitic biological agents for prevention and control of autoimmune diseases
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2255668A2 Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
12/01/2010EP2255194A1 Methods for prognosing the status of tumor patients
12/01/2010EP2254909A1 NON-AGGREGATING HUMAN Vh DOMAINS
12/01/2010EP2254667A2 Treatment of diseases and conditions mediated by eicosanoids
12/01/2010EP2254602A2 Continuous cell programming devices
12/01/2010EP2254599A2 Combination of an iron chelator and an immunosuppressant and use thereof
12/01/2010EP1806141B1 Par-2 antagonists
12/01/2010EP1569679B1 Chaperonin 10 immunosuppression
12/01/2010EP1513552B1 Packaged virus-like particles in combination with cpg for use as adjuvants with allergens : method of preparation and use
12/01/2010EP1427441B1 COMPOSITE SUPERIMMUNOGEN FOR BI-FUNCTIONAL VACCINE Tat-gp160 FOR USE IN THE TREATMENT OF AIDS
12/01/2010EP1372706B1 Proteosome-liposaccharide vaccine adjuvant
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN1617703B Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof
12/01/2010CN101903403A CD19 binding agents and uses thereof
1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 1172